| AAA | 0.00% | |
|---|---|---|
| AA | 0.00% | |
| A | 0.00% | |
| BBB | 0.00% |
| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 15.70 CAD | -0.17 (-1.07%) | 15.25 - 16.48 | 78.1 thousand (Above Avg) |
Market data as of 3:53PM 06/19/13. Quotes are delayed by at least 15 min.
"The investment seeks to replicate, net of expenses, the Barclays Capital U.S. High Yield Very Liquid Index CAD Hedged. The fund will invest in securities that comprise the index. It will generally reflect the exposure from an investment in high yield corporate bonds issued in the US (in USD) with a term to maturity primarily greater than one year and a below investment grade credit rating."
| Open | 15.92 |
|---|---|
| Previous Close | 15.87 |
| Day's Range | 15.70 - 15.96 |
| Avg Volume (10 Day) | 54.2K |
| Total Assets | $678.62M |
| Expense Ratio | -- |
| Yield (Trailing 12 Mo.) | 6.77% |
| Fund Inception | 10/20/2009 |
| Timeframe | TSE:ZHY | S&P 500 | High Yield Fixed Income |
|---|---|---|---|
| 1 Month | -0.92% | 2.34% | -0.24% |
| 3 Month | 1.92% | 8.22% | 1.08% |
| Year-to-Date | 3.16% | 15.37% | 2.97% |
| 1 Year | 14.18% | 27.28% | 9.49% |
| 3 Year | 11.12% | 16.87% | 8.37% |
| 5 Year | -- | 5.43% | 6.48% |
| 10 Year | -- | 7.58% | 5.37% |
| Since Inception | 9.98% | 10.42% | -- |
| AAA | 0.00% | |
|---|---|---|
| AA | 0.00% | |
| A | 0.00% | |
| BBB | 0.00% |
| BB | 35.40% | |
|---|---|---|
| B | 44.70% | |
| Below B | 19.90% | |
| Not Rated | 0.00% |
| Company | YTD Return | % of Assets |
|---|---|---|
| JNK | -- | 2.12% |
| Hca 6.5% | -- | 1.40% |
| First Data 12.625% | -- | 1.19% |
| Sprint Nextel 144A 9% | -- | 0.85% |
| Chs / Cmnty Health Sys 8% | -- | 0.81% |
| Everest Acq Llc/Finance 9.375% | -- | 0.78% |
| Engy Future Inter Hldg Co Ll 10% | -- | 0.77% |
| Samson Invt 144A 9.75% | -- | 0.74% |
| Biomet 144A 6.5% | -- | 0.72% |
| Reynolds Grp Issuer 5.75% | -- | 0.70% |
| Valuation | TSE:ZHY | Category Range |
|---|---|---|
| Price/Earnings | -- | |
| Price/Book | -- | |
| Price/Sales | -- | |
| Price/Cash Flow | -- | |
| Dividend Yield | ||
| LT Earnings | ||
| Historical Earnings | ||
| Sales Growth | ||
| Cash-Flow Growth | ||
| Book-Value Growth |
| Rate Sensitivity | |||
|---|---|---|---|
| High | |||
| Mid | |||
| Low | |||
![]() | ![]() | ![]() |

| Rating | vs Category | |
|---|---|---|
| Overall | ![]() ![]() ![]() ![]() | |
| Risk | High | |
| Return | High |
| Beta | 0.49 |
|---|---|
| Standard Deviation | 8.08 |
| Alpha | 4.74 |
| Sharpe Ratio | 1.24 |
| Mean | 11.48 |
| R-Squared | 9.09 |
| Pretax Return | 11.12% |
|---|---|
| Tax-adjusted Return | 8.05% |
| Tax Cost Ratio | 2.76% |
| Potential Cap Gains | -- |